Andrew Cheng - Insider Trading & Ownership

Location
170 Harbor Way, 3 Rd Floor, C/O Akero Therapeutics, Inc., South San Francisco, CA
Summary
The estimated net worth of Andrew Cheng is at least $24.3M dollars as of November 13, 2025. Andrew Cheng is the President and CEO, Director of Akero Therapeutics, Inc. and owns shares of Akero Therapeutics, Inc. (AKRO) stock worth about $24.3M. Andrew Cheng is the Director of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $61.8K.
Signature
/s/ Jonathan Young, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Andrew Cheng

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AKRO Akero Therapeutics, Inc. President and CEO, Director $24.3M -$16.3M -40.2% Nov 12, 2025
ABUS Arbutus Biopharma Corp Director $61.8K Jun 3, 2021
VERA Vera Therapeutics, Inc. Director May 14, 2025

Insider Transactions Reported by Andrew Cheng:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.